跳至主要内容
临床试验/NCT03022838
NCT03022838终止2 期

The Effects of Caffeine Withdrawal on Migraine - a Randomized, Double-blind, Crossover Study

Nordlandssykehuset HF3 个研究点 分布在 1 个国家目标入组 10 人开始时间: 2017年2月28日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
2 期
状态
终止
入组人数
10
试验地点
3
主要终点
Migraine days

研究概览

简要总结

Sporadic and chronic dietary consumption of caffeine has substantial biological effects on the nervous system. The effects on migraine are at large not known. In this study we want to assess the effects of caffeine withdrawal on migraine.

详细描述

The actions of caffeine as an antagonist of adenosine receptors have been extensively studied, and there is no doubt that both daily and sporadic dietary consumption of caffeine has substantial biological effects on the nervous system. The current opinion is that caffeine both can cure and trigger headaches. Caffeine is a component of many combination drugs marketed for the relief of headaches, but on the other hand it is strongly incriminated as a risk factor for developing chronic headache. Withdrawal may cause symptom constellations similar to the migraine syndrome. Further, caffeine consumption may affect sleep and alertness, possibly influencing the risk of migraine attacks. .

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Crossover
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • migraine present for at least 1 year and fulfilling diagnostic criteria (ICHD-3 beta)
  • =/> 3 migraine attacks per month
  • no migraine prophylaxis the last month
  • consumption =/> 300 mg and </= 800 mg caffeine per day the last month
  • signed consent

排除标准

  • suspicion of medication-overuse headache
  • pregnancy and breast feeding
  • serious co-morbidity or conditions requiring Medical treatment or caution
  • working night shift
  • use of drugs with moderate or major interactions with caffeine

研究组 & 干预措施

Caffeine

Active Comparator

Caffeine tablets (Recip) 100 mg, 300-800 mg

干预措施: Caffeine (Drug)

Placebo

Placebo Comparator

Placebo tablets

干预措施: Caffeine (Drug)

结局指标

主要结局

Migraine days

时间窗: 10 weeks

Reduction from baseline in monthly migraine days (withdrawal vs. caffeine)

次要结局

  • Sleep improvement(10 weeks)
  • Withdrawal symptoms and/or syndrome (according to criteria)(2 first days after caffeine withdrawal(withdrawal vs. caffeine))
  • Migraine attacks(10 weeks)
  • Quality of life(10 weeks)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (3)

Loading locations...

相似试验